glp-1 aspiration How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Endoscopy & GLP-1 Receptor Agonists

In May, Novo Nordisk agreed a partnership deal with Septerna to jointly discover and develop multiple oral small molecule obesity and cardiometabolic disease drugs

Meanwhile, Semaglutide GLP-1 (Ozempic, Wegovy) has shown promising results in terms of weight loss, despite its primary use for treating type 2 diabetes

also approved for chronic weight management in adults (refer to current MHRA and NICE Technology Appraisal guidance for the applicable indication and eligibility criteria) [4] [7] Orlistat available on NHS prescription and over the counter Naltrexone/bupropion (Mysimba) available in some settings, though NHS commissioning varies by region [10] NICE Technology Appraisals provide eligibility criteria and commissioning guidance for semaglutide and tirzepatide in weight management

This is shorter than FDA-approved products because compounded formulations undergo less stability testing

If you experience fatigue or increased hair shedding, it may indicate insufficient nutritional intake

For AMPK activation or inhibition, according to the aforementioned procedure (Zhang et al., 2009